Form 8-K - Current report:
SEC Accession No. 0000950170-25-052304
Filing Date
2025-04-09
Accepted
2025-04-09 07:06:54
Documents
14
Period of Report
2025-04-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neog-20250408.htm   iXBRL 8-K 46863
2 EX-10.1 neog-ex10_1.htm EX-10.1 76046
3 EX-99.1 neog-ex99_1.htm EX-99.1 10263
4 GRAPHIC img192722933_0.jpg GRAPHIC 13033
  Complete submission text file 0000950170-25-052304.txt   282945

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20250408.xsd EX-101.SCH 25023
16 EXTRACTED XBRL INSTANCE DOCUMENT neog-20250408_htm.xml XML 4730
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 25823818
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)